2005
DOI: 10.1038/sj.bmt.1704810
|View full text |Cite
|
Sign up to set email alerts
|

Use of natural killer cells in hematopoetic stem cell transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
54
0
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 82 publications
(56 citation statements)
references
References 50 publications
1
54
0
1
Order By: Relevance
“…17 We and others could show that NK cells can be used as adoptive immunotherapy after haploidentical SCT. 32,33 In addition, high levels of NK cells may be protective against the development of GvHD. 34 Immune reconstitution studies, to date, have not measured lymphocyte subsets in short intervals.…”
Section: Discussionmentioning
confidence: 99%
“…17 We and others could show that NK cells can be used as adoptive immunotherapy after haploidentical SCT. 32,33 In addition, high levels of NK cells may be protective against the development of GvHD. 34 Immune reconstitution studies, to date, have not measured lymphocyte subsets in short intervals.…”
Section: Discussionmentioning
confidence: 99%
“…Calculated with the published data, 26 1 Â 10 8 /kg nucleated BM cells include 8 Â 10 6 /kg T cells, 3 Â 10 6 /kg B cells and 2 Â 10 6 /kg nature killer cells. Considering the cell dose used in adaptive immunotherapies with these cells, [27][28][29] this number of T cells can alter the outcome but that of nature killer cells will not. Therefore, we speculated that T cells would be the most likely population affecting relapse rates.…”
Section: Discussionmentioning
confidence: 99%
“…This KIR-mediated recognition of missing self is the basis for donor-versus-recipient NK cell alloreactivity in KIR ligand-mismatched hematopoietic transplants in adult AML, which is extensively being investigated and reviewed by others. [6][7][8][9] Although also endogenous NK cells can target cancer cells and have been proven useful for cancer immunotherapy, 10,11 several hematological malignancies, [12][13][14] including AML, encompass significant impaired NK cell functions contributing to the escape of immune surveillance. In this review, we will discuss these mechanisms in AML, as well as strategies to restore NK-cellmediated anti-leukemia responses.…”
Section: Natural Killer (Nk) Cells T Cells and Dendritic Cells (Dc)mentioning
confidence: 99%